NCT00701662View on ClinicalTrials.gov

A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Multifocal Motor Neuropathy (MMN)
Interventions
BIOLOGICAL

Vivaglobin

Trial Locations (3)

Unknown

San Raffaele Hospital, Milan

Inselspital, Bern

Dept. Clinical Immunology, Oxford Radcliffe Hospitals, Oxford

Sponsors

Lead Sponsor

CSL Behring
All Listed Sponsors
lead

CSL Behring

INDUSTRY